Science Explorer Back to mapMap
Discussion
Researcher · Incyte (United States) · United States

Holly K. Koblish

Holly K. Koblish publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as Cancer Mechanisms and Therapy, Immune cells in cancer and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0002-9745-3561 OpenAlex
World rank
#263,903
of 7,710,434 ranked researchers
Rank in United States
#96,645
of 1,627,098
Works
115
Citations
4.2k
Citations per work
36.4
h-index
26
i10-index 35Top 20% in Molecular Biology
Holly K. Koblish

What does Holly K. Koblish research?

Holly K. Koblish's work is mostly in Medicine (34%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (14%).

Life Sciences: 41 works · 35.5% of their workBiochemistry, Genetics and Molecular Biology: 24 works · 21.3% of their workMolecular Biology: 24 works · 21.3% of their workImmunology and Microbiology: 16 works · 14.2% of their workImmunology: 16 works · 14.2% of their workHealth Sciences: 40 works · 34.5% of their workMedicine: 40 works · 34.5% of their workOncology: 19 works · 16.2% of their workPathology and Forensic Medicine: 8 works · 6.6% of their workHematology: 7 works · 6.1% of their workGenetics: 6 works · 5.6% of their workEverything else: 35 works · 30.0% of their workTHEIR WORKHolly K. Koblish115works
Life Sciences36%Health Sciences34%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2421.3%
    2. Immunology and Microbiology1614.2%
    1. Medicine4034.5%
  3. Everything else3530.0%
  1. 1Molecular Biology21% of their works
  2. 2Oncology16% of their works
  3. 3Immunology14% of their works
  4. 4Pathology and Forensic Medicine7% of their works
  5. 5Hematology6% of their works
  6. 6Genetics6% of their works

Research topics

Which keywords describe Holly K. Koblish's research?

The keywords of their largest research topics: Cancer, Metabolism, Tumor Microenvironment, Pim Oncogenes, Tumorigenesis, Activation, Immune Checkpoint Blockade and Macrophage.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer162 topics
  2. Metabolism162 topics
  3. Tumor Microenvironment162 topics
  4. Pim Oncogenes121 topic
  5. Tumorigenesis121 topic
  6. Activation101 topic
  7. Immune Checkpoint Blockade101 topic
  8. Macrophage101 topic
  9. PD-1 and PD-L1101 topic
  10. Cell Cycle81 topic
  11. p5381 topic
  12. Cytokines61 topic
  13. DNA Methylation61 topic
  14. FGF2161 topic
  15. Fibroblast Growth Factor61 topic
  16. HIF-161 topic
  17. Histone Modification61 topic
  18. Neuroinflammation61 topic
  19. Warburg Effect61 topic

Where does Holly K. Koblish work?

Holly K. Koblish's main affiliation in the publication record is Incyte (United States), United States.

How many publications and citations does Holly K. Koblish have?

OpenAlex counts 115 works and 4,182 citations for Holly K. Koblish, an h-index of 26, ranking #263,903 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Holly K. Koblish. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.